StockData
Bio Key International Inc logo

Bio Key International Inc (BKYI) stock

BKYINasdaqServices-Prepackaged SoftwareFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/3073% below fair value
$1.99+0.05 (+2.58%)

Close on Nov 18, 2026Market cap $2.86MP/E –Yield –

Earnings

Bio Key International's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 3, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$1.48M
-4.3% on a year earlier
EPS, Q3 FY2026
-$4.01
-$0.15 a year earlier
Latest guidance
Reaffirmed
May 18, 2026 · 2 items

Quarterly results

Revenue and earnings per share from each of Bio Key International's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 3, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 13, 2026before the open$1.48M-4.3%-$4.01Release
Q2 FY2026ended Jun 30, 2026Aug 14, 2026before the open$1.92M+13.1%-$0.56Release
Q1 FY2026ended Mar 31, 2026May 18, 2026before the open$2.15M+33.5%-$0.15Release
Q4 FY2025ended Dec 31, 2025Mar 4, 2026before the open–––Release
Q3 FY2025ended Sep 30, 2025Nov 14, 2025before the open$1.55M-26.2%-$0.15Release
Q2 FY2025ended Jun 30, 2025Aug 13, 2025before the open$1.70M+54.3%-$0.20Release
Q1 FY2025ended Mar 31, 2025May 15, 2025after the close$1.61M-26.9%-$0.16Release
Q4 FY2024ended Dec 31, 2024Mar 27, 2025before the open$1.46M–-$0.53Release
Q3 FY2024ended Sep 30, 2024Nov 15, 2024before the open$2.10M+16.7%-$0.39Release
Q2 FY2024ended Jun 30, 2024Aug 15, 2024after the close$1.10M-42.1%-$1.00Release
Q1 FY2024ended Mar 31, 2024Jun 17, 2024after the close$2.20M-29.0%-$0.32Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Bio Key International's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
revenuesFY2026$5.00M$5.00MReaffirmedMay 18, 2026
revenues expected to growFY2026+50%–NewApr 20, 2026

Guidance vs results

The last range Bio Key International gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
Q2 FY2026Revenue$2.80M$1.92MBelow range
Q2 FY2026Revenue growth+65%+13.15%Below range
Q1 FY2026Revenue$2.20M$2.15MBelow range
Q1 FY2026Revenue growth+37%+33.5%Below range

Guidance history

Every forecast Bio Key International put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
May 18, 2026revenuesQ2 FY2025$2.80MNew
May 18, 2026revenuesFY2026$5.00MReaffirmed
Apr 20, 2026revenues expected to growQ1 FY2026+37%New
Apr 20, 2026revenuesQ1 FY2026$2.20MNew
Apr 20, 2026revenues expected to growQ2 FY2026+65%New
Apr 20, 2026revenuesQ2 FY2026$2.80MNew
Apr 20, 2026revenues expected to growFY2026+50%New
Apr 20, 2026revenuesFY2026$5.00MNew
Nov 14, 2025full year revenueFY2025$6.50M – $7.00MNew
Nov 15, 2024revenuesFY2024$7.75MNew
Nov 15, 2022full-year revenuesFY2022$7.00M – $9.00MLowered
Aug 12, 2022revenue guidanceFY2022$10.00M – $13.00MReaffirmed
May 16, 2022revenue guidanceFY2022$10.00M – $13.00MReaffirmed
Mar 29, 2022revenue guidanceFY2022$10.00M – $13.00MNew
Nov 16, 2021revenueFY2021$5.50M – $7.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Bio Key International filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Update
  4. Update
  5. Results
  6. Update
  7. News
  8. Update
  9. Results
  10. Results
  11. Results
  12. Results
  13. Results
  14. Results
  15. Update

See a number that looks wrong?